Medifast (NYSE: MED) reported Q3 EPS of ($0.21), $0.09 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $89.4 million versus the consensus estimate of $93.8 million.

For earnings history and earnings-related data on Medifast (MED) click here.